SOPHARMA AD: Consolidated quarterly financial report

opublikowano: 2026-05-29 13:12

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_Q1_2026_cons_Financial statements_pdf.rar

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

149

/

2026

Date of issue:

2026-05-29

Short name of the issuer

SOPHARMA AD

Subject

Consolidated quarterly financial report

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Consolidated quarterly financial report

Annexes

File

Description

SFA_Q1_2026_cons_Financial statements_pdf.rar

Consolidated quarterly financial report

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date

Name

Position / Function

Signature

2026-05-29

Ognian Ivanov Donev

Executive Director